Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mediscience Technology was a medical device company specializing in the development of photonic-based diagnostic tools for the early detection of cancer. Its flagship technology, the Cancer Detection - Real-Time (CD-RAT) system, employed fluorescence spectroscopy to provide an "optical biopsy," allowing for the immediate identification of malignant tissues. The company focused on applications for cervical, skin, and esophageal cancers, aiming to reduce the need for invasive surgical biopsies. While the technology underwent clinical trials and the company was publicly traded, it ultimately ceased active operations following regulatory and financial challenges. The core intellectual property was developed in collaboration with the City College of New York. The company's approach was considered pioneering in the field of non-invasive diagnostics during the 1990s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediscience Technology.